Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice job everyone! Nice team we've got here.
That wall at 48 looks juicy
Let's keep slapping !! We got this !!
Let's beat the shorts slap we got this
Slap slap!!
Check out the bid on $ADMD wow!!!!
Look at the bid support!
WHO'S READY FOR FDA APPROVAL
WHO'S READY TO SEE SOME BIG ASK SLAPS
Closing green will be fun eod
Lol ate that wall
I'm buying, idc about you.
ADMD Insider Buying - http://www.secform4.com/insider-trading/1449349.htm
ADMD- Battele acquires over 10% of AMIC (ADMD)- Battelle Acquires over 10% of Advanced Medical Isotope Corporation
KENNEWICK, Wash., July 7, 2014 (PRNewswire) – Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC’s outstanding Common Stock. Battelle is a leading international science and technology enterprise that explores emerging areas of science and develops and commercializes technology.
license agreements with Battelle for 10 patents related to AMICs brachytherapy products
In 2011, AMIC entered into license agreements with Battelle for 10 patents related to AMICs brachytherapy products; and in 2012, AMIC entered into an exclusive license agreement with Battelle for use of Battelle’s patented brachytherapy gel technology.
license agreements with Battelle for 10 patents related to AMICs brachytherapy products
In 2011, AMIC entered into license agreements with Battelle for 10 patents related to AMICs brachytherapy products; and in 2012, AMIC entered into an exclusive license agreement with Battelle for use of Battelle’s patented brachytherapy gel technology.
ADMD awarded PATENT! Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted
KENNEWICK, Wash., Sept. 16, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a patent was awarded for technology related to its brachytherapy products. AMIC's rights for the newly issued patent arise from its license from Battelle, under which AMIC exclusively licensed technologies developed at Pacific Northwest National Laboratory and the University of Utah for its proposed brachytherapy products. The patent awarded, US 8,821,364 B2, relates to AMIC's brachytherapy seed product and is entitled: Brachytherapy Seed with Fast Dissolving Matrix for Optimal Delivery of Radionuclides to Cancer Tissue. AMIC will support Battelle in further patent protection for additional markets consistent with AMIC's overall global commercialization strategy.
ADMD awarded LSDF grant as commercialization partner-
Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner -KENNEWICK, Wash., Dec. 19, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a Life Sciences Discovery Fund (LSDF) Proof of Concept Grant has been awarded for which AMIC is the commercialization partner. The award was made to Washington State University (WSU) for the proposal titled "Optimized Injectable Radiogels for High-dose Therapy of Non-resectable Solid Tumors," submitted by Principal Investigator Dr. Darrell Fisher, in the amount of $250,000. AMIC will receive a portion of the award by supplying product to WSU for the study as well as providing scientific and technical support. AMIC plans to use the data generated during the study to support the commercialization of the Company's brachytherapy products. Dr. Darrell Fisher serves on the AMIC Medical Advisory Board.
$715,735 volume today. This is nothing yet, $ADMD.
$ADMD $$$$$$$$$$$$$$$$
Lol that's nothing just wait a little you'll see
Ninja that wall at 48 looks juicy doesn't it
Told you just like that walls gone
That 46 wall I have 1 word for you and it's cya
CHDN moving up hahaha
Let's all focus on ADMD now thanks
CHDN - $12.9 BILLION RAISED THROUGH --- TRANSACTIONS. GL FINDING ANOTHER OTC STOCK WITH CHDN
SOME OF YOU DON'T UNDERSTAND THE POWER BEHIND ADMD SOON AND REAL SOON YOU'LL SEE WHT ADMD REALLY IS. HAHAHAHA
ATTENTION TO ALL -------
CHDN IS BDDING 5 MILLION, CHDN IS A PRIVATE INVESTMENT BANKING FIRM WITH BILLIONS OF DOLLARS MADE. ----- GOOD LUCK IT'S TIME TO GO UP FROM HERE.
Ok cool why are you posting if you have no shares??
No dilution learn to read the PR'S
Shorts are in trouble LOL
Strong bid
Going to be a nice week here.
THIS IS JUST THE START !!! ADMD $$$$$$$
$ADMD boooom let's start it
Us retail investors are good. Dw lol
$ADMD $$$$$$$$$$
Yes
Found some new news and it's good.